On August 21, 2026, Neuralink published an exhaustive clinical update on its PRIME Study, detailing the achievements of its second human trial participant, Alex, who suffers from a spinal cord injury.
Following the landmark first human implant in January 2024, engineers encountered an unexpected challenge: natural brain motion caused roughly 85% of the ultra-thin electrode threads to retract slightly from the cerebral cortex, necessitating software compensation to restore cursor tracking speed. For Alex's procedure at Barrow Neurological Institute in Phoenix, the surgical team implemented critical protocol changes: reducing brain motion during insertion, placing electrode threads deeper into sulci grooves, and sealing the cranial gap flush to the dura mater.
The results were immediate and decisive. Alex shattered previous brain-computer interface benchmarks for task versatility. Beyond navigating web interfaces, Alex actively utilizes Autodesk Fusion 360 to design physical mounts and brackets, controlling complex 3D rotation, extrusion, and constraint tools with pure neural motor intention.
On the second day post-implant, Alex connected the BCI to Counter-Strike 2, using the neural implant to aim and look around while operating an adaptive quadstick with his mouth for movement, outperforming his pre-injury gaming reflexes.
Neuralink confirmed that the N1 implant's internal spike-sorting algorithms continue to decode intention with sub-millisecond latency, marking a transformative leap in digital autonomy for paralyzed individuals.